Effect of mindfulness on anxiety and depression in insomnia patients: A systematic review and meta-analysis.
anxiety
depression
insomnia
meta-analysis
mindfulness
Journal
Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006
Informations de publication
Date de publication:
2023
2023
Historique:
received:
15
12
2022
accepted:
07
02
2023
entrez:
20
3
2023
pubmed:
21
3
2023
medline:
21
3
2023
Statut:
epublish
Résumé
As a common clinical symptom, insomnia has a high incidence of combined mental illness and it is also a risk factor for the development of depression, anxiety and suicide. As a new concept in the field of health in recent years, mindfulness therapy can improve insomnia, anxiety and depression, which is a new way to solve such diseases. This study aims to systematically evaluate the effects of mindfulness compared with conventional treatment on scores of the Hamilton Depression Scale (HAMD), Hamilton Anxiety Scale (HAMA), Self-Rating Depression Scale (SDS) and Self-Rating Anxiety Scale (SAS) in people with insomnia and anxiety-depressive symptoms. Articles published before October 2022 were searched from seven databases and included in randomized controlled trials (RCTs) to evaluate mindfulness therapy. The assessment tool of Cochrane bias risk was used to evaluate the methodological quality of the literature. The main outcome indicators were HAMD and HAMA scores, and the secondary outcome indicators were SDS and SAS scores. Ten randomized controlled trials including 1,058 subjects were systematically evaluated and meta-analyzed in this study. In the main outcome indicators, there was a significant difference between mindfulness therapy and conventional treatment in reducing HAMD score (MD: -3.67, 95% CI: -5.22-2.11, For the people with insomnia, anxiety and depression, the use of conventional treatment with the addition of 4-12 weeks of mindfulness treatment can significantly improve anxiety and depression symptoms of patients. This is a new diagnosis and treatment idea recommended for insomniacs with or without anxiety and depression symptoms. Due to the methodological defects in the included study and the limited sample size of this paper, more well-designed randomized controlled trials are needed for verification.
Sections du résumé
Background
UNASSIGNED
As a common clinical symptom, insomnia has a high incidence of combined mental illness and it is also a risk factor for the development of depression, anxiety and suicide. As a new concept in the field of health in recent years, mindfulness therapy can improve insomnia, anxiety and depression, which is a new way to solve such diseases.
Objective
UNASSIGNED
This study aims to systematically evaluate the effects of mindfulness compared with conventional treatment on scores of the Hamilton Depression Scale (HAMD), Hamilton Anxiety Scale (HAMA), Self-Rating Depression Scale (SDS) and Self-Rating Anxiety Scale (SAS) in people with insomnia and anxiety-depressive symptoms.
Methods
UNASSIGNED
Articles published before October 2022 were searched from seven databases and included in randomized controlled trials (RCTs) to evaluate mindfulness therapy. The assessment tool of Cochrane bias risk was used to evaluate the methodological quality of the literature. The main outcome indicators were HAMD and HAMA scores, and the secondary outcome indicators were SDS and SAS scores.
Results
UNASSIGNED
Ten randomized controlled trials including 1,058 subjects were systematically evaluated and meta-analyzed in this study. In the main outcome indicators, there was a significant difference between mindfulness therapy and conventional treatment in reducing HAMD score (MD: -3.67, 95% CI: -5.22-2.11,
Conclusion
UNASSIGNED
For the people with insomnia, anxiety and depression, the use of conventional treatment with the addition of 4-12 weeks of mindfulness treatment can significantly improve anxiety and depression symptoms of patients. This is a new diagnosis and treatment idea recommended for insomniacs with or without anxiety and depression symptoms. Due to the methodological defects in the included study and the limited sample size of this paper, more well-designed randomized controlled trials are needed for verification.
Identifiants
pubmed: 36937735
doi: 10.3389/fpsyt.2023.1124344
pmc: PMC10018191
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1124344Informations de copyright
Copyright © 2023 Li, Sun, Li, Feng, Wang, Qin, Zhang, Wang, Wang, Cai, Song, Han and Liu.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Int J Psychophysiol. 2009 Feb;71(2):170-6
pubmed: 18854202
Complement Ther Clin Pract. 2016 May;23:59-63
pubmed: 27157960
J Sci Med Sport. 2018 Apr;21(4):352-357
pubmed: 28866110
Science. 2003 Jul 18;301(5631):386-9
pubmed: 12869766
Mol Psychiatry. 2017 Apr;22(4):527-536
pubmed: 27528460
Biol Psychiatry. 2006 Dec 15;60(12):1364-71
pubmed: 16952333
J Med Syst. 2019 Dec 13;44(1):28
pubmed: 31834531
Lancet Psychiatry. 2016 Apr;3(4):333-41
pubmed: 26827250
Sleep. 2013 Jul 01;36(7):1059-1068
pubmed: 23814343
J Clin Psychol. 2013 Oct;69(10):1043-55
pubmed: 23109266
J Psychiatr Res. 2015 Sep;68:270-82
pubmed: 26228429
BMC Res Notes. 2013 Feb 11;6:59
pubmed: 23398959
J Affect Disord. 2011 Dec;135(1-3):10-9
pubmed: 21300408
Neurosci Biobehav Rev. 2017 Mar;74(Pt B):330-341
pubmed: 27185286
BMJ. 2012 Sep 27;345:e6231
pubmed: 23045258
JAMA. 2008 Sep 17;300(11):1350-2
pubmed: 18799450
Brain Cogn. 2018 Aug;125:100-105
pubmed: 29936408
Psychopathology. 2002 Mar-Jun;35(2-3):171-5
pubmed: 12145505
Neuroimage. 2009 Sep;47(3):836-51
pubmed: 19465135
Sleep Med Rev. 2002 Apr;6(2):97-111
pubmed: 12531146
Sleep Med Rev. 2001 Feb;5(1):47-61
pubmed: 12531044
J Pers Soc Psychol. 2003 Apr;84(4):822-48
pubmed: 12703651
Psychoneuroendocrinology. 2017 Dec;86:152-168
pubmed: 28963884
J Card Fail. 2018 Mar;24(3):186-201
pubmed: 28939458
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Science. 2010 Nov 12;330(6006):932
pubmed: 21071660
PLoS Med. 2013 Nov;10(11):e1001547
pubmed: 24223526
Neuropsychiatr Dis Treat. 2011;7(Suppl 1):3-7
pubmed: 21750622
J Acupunct Meridian Stud. 2009 Sep;2(3):171-81
pubmed: 20633489
Clin Psychol Rev. 2017 Feb;51:48-59
pubmed: 27835764
Int J Psychophysiol. 2005 Feb;55(2):199-207
pubmed: 15649551